Literature DB >> 20463078

OrfA downregulates feline immunodeficiency virus primary receptor CD134 on the host cell surface and is important in viral infection.

Yang Hong1, Elizabeth Fink, Qiong-Ying Hu, William B Kiosses, John H Elder.   

Abstract

Feline immunodeficiency virus (FIV) OrfA is an accessory protein that is critical for productive viral replication and infection in T cells. Here, we show that OrfA acts to markedly reduce cell surface expression of the FIV primary binding receptor. Downregulation does not occur at the transcriptional or translational level in that the amounts of CD134 mRNA and protein in total cell lysates are not altered between parental 104-C1 T cells and the same cell line stably expressing OrfA (104-C1-OrfA). Analysis by confocal microscopy revealed significant accumulation of CD134 in the Golgi apparatus of 104-C1 cells expressing OrfA. OrfA does not cause a generalized disruption of membrane trafficking in that surface expression of CD9 is unaffected by OrfA overexpression. Consistent with the above observations, OrfA-negative FIV-34TF10 productively infects CrFK (CD134-negative) and 104-C1-OrfA (CD134 downregulated by OrfA) cells but fails to productively infect either 104-C1 (CD134-positive) cells or GFox (CrFK cells overexpressing CD134) cells. FIV-34TF10 in which the OrfA reading frame is open (OrfArep) productively infects CrFK, GFox, 104-C1, and 104-C1-OrfA cells. We hypothesize that reduced surface expression of the receptor, a hallmark of retrovirus infections, may facilitate an increase in virus release from the infected cell by minimizing receptor interactions with budding virus particles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463078      PMCID: PMC2898258          DOI: 10.1128/JVI.00434-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

Review 2.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment.

Authors:  Michael H Malim; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-06-12       Impact factor: 21.023

3.  Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor.

Authors:  Aymeric de Parseval; Udayan Chatterji; Peiqing Sun; John H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

5.  Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest.

Authors:  Malou C Gemeniano; Earl T Sawai; Ellen E Sparger
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

6.  Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.

Authors:  Udayan Chatterji; Aymeric de Parseval; John H Elder
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Use of CD134 as a primary receptor by the feline immunodeficiency virus.

Authors:  Masayuki Shimojima; Takayuki Miyazawa; Yasuhiro Ikeda; Elizabeth L McMonagle; Hayley Haining; Hiroomi Akashi; Yasuhiro Takeuchi; Margaret J Hosie; Brian J Willett
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

8.  Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.

Authors:  Malou C Gemeniano; Earl T Sawai; Christian M Leutenegger; Ellen E Sparger
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells.

Authors:  Karine Levesque; Yong-Sen Zhao; Eric A Cohen
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

10.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.

Authors:  Bastien Mangeat; Priscilla Turelli; Gersende Caron; Marc Friedli; Luc Perrin; Didier Trono
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

View more
  8 in total

1.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.

Authors:  James H Morrison; Rebekah B Guevara; Adriana C Marcano; Dyana T Saenz; Hind J Fadel; Daniel K Rogstad; Eric M Poeschla
Journal:  J Virol       Date:  2014-01-03       Impact factor: 5.103

3.  Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.

Authors:  Qiong-Ying Hu; Elizabeth Fink; John H Elder
Journal:  Retrovirology (Auckl)       Date:  2012-07-11

Review 4.  The molecular biology of feline immunodeficiency virus (FIV).

Authors:  Julia C Kenyon; Andrew M L Lever
Journal:  Viruses       Date:  2011-11-09       Impact factor: 5.048

5.  Construction and testing of orfA +/- FIV reporter viruses.

Authors:  Hind J Fadel; Dyana T Saenz; Eric M Poeschla
Journal:  Viruses       Date:  2012-01-23       Impact factor: 5.048

Review 6.  Cellular restriction factors of feline immunodeficiency virus.

Authors:  Jörg Zielonka; Carsten Münk
Journal:  Viruses       Date:  2011-10-21       Impact factor: 5.818

Review 7.  Applications of the FIV Model to Study HIV Pathogenesis.

Authors:  Craig Miller; Zaid Abdo; Aaron Ericsson; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2018-04-20       Impact factor: 5.048

Review 8.  Properties and Functions of Feline Immunodeficiency Virus Gag Domains in Virion Assembly and Budding.

Authors:  Silvia A González; José L Affranchino
Journal:  Viruses       Date:  2018-05-16       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.